世界のギランバレー症候群市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Guillain-Barré Syndrome Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2642 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、ギランバレー症候群のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（静脈内免疫グロブリン、血漿交換、その他）、用途別市場規模（病院薬局、小売薬局、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ギランバレー症候群の市場動向 ・企業の競争状況、市場シェア ・ギランバレー症候群の種類別市場規模（静脈内免疫グロブリン、血漿交換、その他） ・ギランバレー症候群の用途別市場規模（病院薬局、小売薬局、その他） ・ギランバレー症候群の北米市場規模2016-2027（アメリカ、カナダ） ・ギランバレー症候群のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ギランバレー症候群のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ギランバレー症候群の中南米市場規模2016-2027（メキシコ、ブラジル） ・ギランバレー症候群の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Grifols、CSL Behring、Octapharma、Nihon Pharmaceutical、Akari Therapeutics、China Biologic Products Holdings、Biotest、Kedrion） ・結論

Guillain-Barré Syndrome is a rapid-onset muscle weakness caused by the immune system damaging the peripheral nervous system.

Market Analysis and Insights: Global Guillain-Barré Syndrome Market
The global Guillain-Barré Syndrome market size is projected to reach US$ 531.3 million by 2026, from US$ 435.9 million in 2019, at a CAGR of 2.8% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Guillain-Barré Syndrome market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Guillain-Barré Syndrome market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Guillain-Barré Syndrome market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Guillain-Barré Syndrome market.

Global Guillain-Barré Syndrome Scope and Market Size
Guillain-Barré Syndrome market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Guillain-Barré Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Intravenous Immunoglobulin
Plasma Exchange
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Grifols
CSL Behring
Octapharma
Nihon Pharmaceutical
Akari Therapeutics
China Biologic Products Holdings
Biotest
Kedrion

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Guillain-Barré Syndrome Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Intravenous Immunoglobulin
1.2.3 Plasma Exchange
1.2.4 Others
1.3 Market by Application
1.3.1 Global Guillain-Barré Syndrome Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Guillain-Barré Syndrome Market Perspective (2016-2027)
2.2 Guillain-Barré Syndrome Growth Trends by Regions
2.2.1 Guillain-Barré Syndrome Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Guillain-Barré Syndrome Historic Market Share by Regions (2016-2021)
2.2.3 Guillain-Barré Syndrome Forecasted Market Size by Regions (2022-2027)
2.3 Guillain-Barré Syndrome Industry Dynamic
2.3.1 Guillain-Barré Syndrome Market Trends
2.3.2 Guillain-Barré Syndrome Market Drivers
2.3.3 Guillain-Barré Syndrome Market Challenges
2.3.4 Guillain-Barré Syndrome Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Guillain-Barré Syndrome Players by Revenue
3.1.1 Global Top Guillain-Barré Syndrome Players by Revenue (2016-2021)
3.1.2 Global Guillain-Barré Syndrome Revenue Market Share by Players (2016-2021)
3.2 Global Guillain-Barré Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Guillain-Barré Syndrome Revenue
3.4 Global Guillain-Barré Syndrome Market Concentration Ratio
3.4.1 Global Guillain-Barré Syndrome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Guillain-Barré Syndrome Revenue in 2020
3.5 Guillain-Barré Syndrome Key Players Head office and Area Served
3.6 Key Players Guillain-Barré Syndrome Product Solution and Service
3.7 Date of Enter into Guillain-Barré Syndrome Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Guillain-Barré Syndrome Breakdown Data by Type
4.1 Global Guillain-Barré Syndrome Historic Market Size by Type (2016-2021)
4.2 Global Guillain-Barré Syndrome Forecasted Market Size by Type (2022-2027)

5 Guillain-Barré Syndrome Breakdown Data by Application
5.1 Global Guillain-Barré Syndrome Historic Market Size by Application (2016-2021)
5.2 Global Guillain-Barré Syndrome Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Guillain-Barré Syndrome Market Size (2016-2027)
6.2 North America Guillain-Barré Syndrome Market Size by Type
6.2.1 North America Guillain-Barré Syndrome Market Size by Type (2016-2021)
6.2.2 North America Guillain-Barré Syndrome Market Size by Type (2022-2027)
6.2.3 North America Guillain-Barré Syndrome Market Size by Type (2016-2027)
6.3 North America Guillain-Barré Syndrome Market Size by Application
6.3.1 North America Guillain-Barré Syndrome Market Size by Application (2016-2021)
6.3.2 North America Guillain-Barré Syndrome Market Size by Application (2022-2027)
6.3.3 North America Guillain-Barré Syndrome Market Size by Application (2016-2027)
6.4 North America Guillain-Barré Syndrome Market Size by Country
6.4.1 North America Guillain-Barré Syndrome Market Size by Country (2016-2021)
6.4.2 North America Guillain-Barré Syndrome Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Guillain-Barré Syndrome Market Size (2016-2027)
7.2 Europe Guillain-Barré Syndrome Market Size by Type
7.2.1 Europe Guillain-Barré Syndrome Market Size by Type (2016-2021)
7.2.2 Europe Guillain-Barré Syndrome Market Size by Type (2022-2027)
7.2.3 Europe Guillain-Barré Syndrome Market Size by Type (2016-2027)
7.3 Europe Guillain-Barré Syndrome Market Size by Application
7.3.1 Europe Guillain-Barré Syndrome Market Size by Application (2016-2021)
7.3.2 Europe Guillain-Barré Syndrome Market Size by Application (2022-2027)
7.3.3 Europe Guillain-Barré Syndrome Market Size by Application (2016-2027)
7.4 Europe Guillain-Barré Syndrome Market Size by Country
7.4.1 Europe Guillain-Barré Syndrome Market Size by Country (2016-2021)
7.4.2 Europe Guillain-Barré Syndrome Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Guillain-Barré Syndrome Market Size (2016-2027)
8.2 Asia-Pacific Guillain-Barré Syndrome Market Size by Type
8.2.1 Asia-Pacific Guillain-Barré Syndrome Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Guillain-Barré Syndrome Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Guillain-Barré Syndrome Market Size by Type (2016-2027)
8.3 Asia-Pacific Guillain-Barré Syndrome Market Size by Application
8.3.1 Asia-Pacific Guillain-Barré Syndrome Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Guillain-Barré Syndrome Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Guillain-Barré Syndrome Market Size by Application (2016-2027)
8.4 Asia-Pacific Guillain-Barré Syndrome Market Size by Region
8.4.1 Asia-Pacific Guillain-Barré Syndrome Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Guillain-Barré Syndrome Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Guillain-Barré Syndrome Market Size (2016-2027)
9.2 Latin America Guillain-Barré Syndrome Market Size by Type
9.2.1 Latin America Guillain-Barré Syndrome Market Size by Type (2016-2021)
9.2.2 Latin America Guillain-Barré Syndrome Market Size by Type (2022-2027)
9.2.3 Latin America Guillain-Barré Syndrome Market Size by Type (2016-2027)
9.3 Latin America Guillain-Barré Syndrome Market Size by Application
9.3.1 Latin America Guillain-Barré Syndrome Market Size by Application (2016-2021)
9.3.2 Latin America Guillain-Barré Syndrome Market Size by Application (2022-2027)
9.3.3 Latin America Guillain-Barré Syndrome Market Size by Application (2016-2027)
9.4 Latin America Guillain-Barré Syndrome Market Size by Country
9.4.1 Latin America Guillain-Barré Syndrome Market Size by Country (2016-2021)
9.4.2 Latin America Guillain-Barré Syndrome Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Guillain-Barré Syndrome Market Size (2016-2027)
10.2 Middle East & Africa Guillain-Barré Syndrome Market Size by Type
10.2.1 Middle East & Africa Guillain-Barré Syndrome Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Guillain-Barré Syndrome Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Guillain-Barré Syndrome Market Size by Type (2016-2027)
10.3 Middle East & Africa Guillain-Barré Syndrome Market Size by Application
10.3.1 Middle East & Africa Guillain-Barré Syndrome Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Guillain-Barré Syndrome Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Guillain-Barré Syndrome Market Size by Application (2016-2027)
10.4 Middle East & Africa Guillain-Barré Syndrome Market Size by Country
10.4.1 Middle East & Africa Guillain-Barré Syndrome Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Guillain-Barré Syndrome Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Grifols
11.1.1 Grifols Company Details
11.1.2 Grifols Business Overview
11.1.3 Grifols Guillain-Barré Syndrome Introduction
11.1.4 Grifols Revenue in Guillain-Barré Syndrome Business (2016-2021)
11.1.5 Grifols Recent Development
11.2 CSL Behring
11.2.1 CSL Behring Company Details
11.2.2 CSL Behring Business Overview
11.2.3 CSL Behring Guillain-Barré Syndrome Introduction
11.2.4 CSL Behring Revenue in Guillain-Barré Syndrome Business (2016-2021)
11.2.5 CSL Behring Recent Development
11.3 Octapharma
11.3.1 Octapharma Company Details
11.3.2 Octapharma Business Overview
11.3.3 Octapharma Guillain-Barré Syndrome Introduction
11.3.4 Octapharma Revenue in Guillain-Barré Syndrome Business (2016-2021)
11.3.5 Octapharma Recent Development
11.4 Nihon Pharmaceutical
11.4.1 Nihon Pharmaceutical Company Details
11.4.2 Nihon Pharmaceutical Business Overview
11.4.3 Nihon Pharmaceutical Guillain-Barré Syndrome Introduction
11.4.4 Nihon Pharmaceutical Revenue in Guillain-Barré Syndrome Business (2016-2021)
11.4.5 Nihon Pharmaceutical Recent Development
11.5 Akari Therapeutics
11.5.1 Akari Therapeutics Company Details
11.5.2 Akari Therapeutics Business Overview
11.5.3 Akari Therapeutics Guillain-Barré Syndrome Introduction
11.5.4 Akari Therapeutics Revenue in Guillain-Barré Syndrome Business (2016-2021)
11.5.5 Akari Therapeutics Recent Development
11.6 China Biologic Products Holdings
11.6.1 China Biologic Products Holdings Company Details
11.6.2 China Biologic Products Holdings Business Overview
11.6.3 China Biologic Products Holdings Guillain-Barré Syndrome Introduction
11.6.4 China Biologic Products Holdings Revenue in Guillain-Barré Syndrome Business (2016-2021)
11.6.5 China Biologic Products Holdings Recent Development
11.7 Biotest
11.7.1 Biotest Company Details
11.7.2 Biotest Business Overview
11.7.3 Biotest Guillain-Barré Syndrome Introduction
11.7.4 Biotest Revenue in Guillain-Barré Syndrome Business (2016-2021)
11.7.5 Biotest Recent Development
11.8 Kedrion
11.8.1 Kedrion Company Details
11.8.2 Kedrion Business Overview
11.8.3 Kedrion Guillain-Barré Syndrome Introduction
11.8.4 Kedrion Revenue in Guillain-Barré Syndrome Business (2016-2021)
11.8.5 Kedrion Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Guillain-Barré Syndrome Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Intravenous Immunoglobulin
Table 3. Key Players of Plasma Exchange
Table 4. Key Players of Others
Table 5. Global Guillain-Barré Syndrome Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Guillain-Barré Syndrome Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Guillain-Barré Syndrome Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Guillain-Barré Syndrome Market Share by Regions (2016-2021)
Table 9. Global Guillain-Barré Syndrome Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Guillain-Barré Syndrome Market Share by Regions (2022-2027)
Table 11. Guillain-Barré Syndrome Market Trends
Table 12. Guillain-Barré Syndrome Market Drivers
Table 13. Guillain-Barré Syndrome Market Challenges
Table 14. Guillain-Barré Syndrome Market Restraints
Table 15. Global Guillain-Barré Syndrome Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Guillain-Barré Syndrome Market Share by Players (2016-2021)
Table 17. Global Top Guillain-Barré Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Guillain-Barré Syndrome as of 2020)
Table 18. Ranking of Global Top Guillain-Barré Syndrome Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Guillain-Barré Syndrome Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Guillain-Barré Syndrome Product Solution and Service
Table 22. Date of Enter into Guillain-Barré Syndrome Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Guillain-Barré Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Guillain-Barré Syndrome Revenue Market Share by Type (2016-2021)
Table 26. Global Guillain-Barré Syndrome Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Guillain-Barré Syndrome Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Guillain-Barré Syndrome Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Guillain-Barré Syndrome Revenue Market Share by Application (2016-2021)
Table 30. Global Guillain-Barré Syndrome Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Guillain-Barré Syndrome Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Guillain-Barré Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Guillain-Barré Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Guillain-Barré Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Guillain-Barré Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Guillain-Barré Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Guillain-Barré Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Guillain-Barré Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Guillain-Barré Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Guillain-Barré Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Guillain-Barré Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Guillain-Barré Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Guillain-Barré Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Guillain-Barré Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Guillain-Barré Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Guillain-Barré Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Guillain-Barré Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Guillain-Barré Syndrome Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Guillain-Barré Syndrome Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Guillain-Barré Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Guillain-Barré Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Guillain-Barré Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Guillain-Barré Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Guillain-Barré Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Guillain-Barré Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Guillain-Barré Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Guillain-Barré Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Guillain-Barré Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Guillain-Barré Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Guillain-Barré Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Guillain-Barré Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 62. Grifols Company Details
Table 63. Grifols Business Overview
Table 64. Grifols Guillain-Barré Syndrome Product
Table 65. Grifols Revenue in Guillain-Barré Syndrome Business (2016-2021) & (US$ Million)
Table 66. Grifols Recent Development
Table 67. CSL Behring Company Details
Table 68. CSL Behring Business Overview
Table 69. CSL Behring Guillain-Barré Syndrome Product
Table 70. CSL Behring Revenue in Guillain-Barré Syndrome Business (2016-2021) & (US$ Million)
Table 71. CSL Behring Recent Development
Table 72. Octapharma Company Details
Table 73. Octapharma Business Overview
Table 74. Octapharma Guillain-Barré Syndrome Product
Table 75. Octapharma Revenue in Guillain-Barré Syndrome Business (2016-2021) & (US$ Million)
Table 76. Octapharma Recent Development
Table 77. Nihon Pharmaceutical Company Details
Table 78. Nihon Pharmaceutical Business Overview
Table 79. Nihon Pharmaceutical Guillain-Barré Syndrome Product
Table 80. Nihon Pharmaceutical Revenue in Guillain-Barré Syndrome Business (2016-2021) & (US$ Million)
Table 81. Nihon Pharmaceutical Recent Development
Table 82. Akari Therapeutics Company Details
Table 83. Akari Therapeutics Business Overview
Table 84. Akari Therapeutics Guillain-Barré Syndrome Product
Table 85. Akari Therapeutics Revenue in Guillain-Barré Syndrome Business (2016-2021) & (US$ Million)
Table 86. Akari Therapeutics Recent Development
Table 87. China Biologic Products Holdings Company Details
Table 88. China Biologic Products Holdings Business Overview
Table 89. China Biologic Products Holdings Guillain-Barré Syndrome Product
Table 90. China Biologic Products Holdings Revenue in Guillain-Barré Syndrome Business (2016-2021) & (US$ Million)
Table 91. China Biologic Products Holdings Recent Development
Table 92. Biotest Company Details
Table 93. Biotest Business Overview
Table 94. Biotest Guillain-Barré Syndrome Product
Table 95. Biotest Revenue in Guillain-Barré Syndrome Business (2016-2021) & (US$ Million)
Table 96. Biotest Recent Development
Table 97. Kedrion Company Details
Table 98. Kedrion Business Overview
Table 99. Kedrion Revenue in Guillain-Barré Syndrome Business (2016-2021) & (US$ Million)
Table 100. Kedrion Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Guillain-Barré Syndrome Market Share by Type: 2020 VS 2027
Figure 2. Intravenous Immunoglobulin Features
Figure 3. Plasma Exchange Features
Figure 4. Others Features
Figure 5. Global Guillain-Barré Syndrome Market Share by Application: 2020 VS 2027
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Others Case Studies
Figure 9. Guillain-Barré Syndrome Report Years Considered
Figure 10. Global Guillain-Barré Syndrome Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Guillain-Barré Syndrome Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Guillain-Barré Syndrome Market Share by Regions: 2020 VS 2027
Figure 13. Global Guillain-Barré Syndrome Market Share by Regions (2022-2027)
Figure 14. Global Guillain-Barré Syndrome Market Share by Players in 2020
Figure 15. Global Top Guillain-Barré Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Guillain-Barré Syndrome as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Guillain-Barré Syndrome Revenue in 2020
Figure 17. Global Guillain-Barré Syndrome Revenue Market Share by Type (2016-2021)
Figure 18. Global Guillain-Barré Syndrome Revenue Market Share by Type (2022-2027)
Figure 19. North America Guillain-Barré Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Guillain-Barré Syndrome Market Share by Type (2016-2027)
Figure 21. North America Guillain-Barré Syndrome Market Share by Application (2016-2027)
Figure 22. North America Guillain-Barré Syndrome Market Share by Country (2016-2027)
Figure 23. United States Guillain-Barré Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Guillain-Barré Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Guillain-Barré Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Guillain-Barré Syndrome Market Share by Type (2016-2027)
Figure 27. Europe Guillain-Barré Syndrome Market Share by Application (2016-2027)
Figure 28. Europe Guillain-Barré Syndrome Market Share by Country (2016-2027)
Figure 29. Germany Guillain-Barré Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Guillain-Barré Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Guillain-Barré Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Guillain-Barré Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Guillain-Barré Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Guillain-Barré Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Guillain-Barré Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Guillain-Barré Syndrome Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Guillain-Barré Syndrome Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Guillain-Barré Syndrome Market Share by Region (2016-2027)
Figure 39. China Guillain-Barré Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Guillain-Barré Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Guillain-Barré Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Guillain-Barré Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Guillain-Barré Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Guillain-Barré Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Guillain-Barré Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Guillain-Barré Syndrome Market Share by Type (2016-2027)
Figure 47. Latin America Guillain-Barré Syndrome Market Share by Application (2016-2027)
Figure 48. Latin America Guillain-Barré Syndrome Market Share by Country (2016-2027)
Figure 49. Mexico Guillain-Barré Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Guillain-Barré Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Guillain-Barré Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Guillain-Barré Syndrome Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Guillain-Barré Syndrome Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Guillain-Barré Syndrome Market Share by Country (2016-2027)
Figure 55. Turkey Guillain-Barré Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Guillain-Barré Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Guillain-Barré Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Grifols Revenue Growth Rate in Guillain-Barré Syndrome Business (2016-2021)
Figure 59. CSL Behring Revenue Growth Rate in Guillain-Barré Syndrome Business (2016-2021)
Figure 60. Octapharma Revenue Growth Rate in Guillain-Barré Syndrome Business (2016-2021)
Figure 61. Nihon Pharmaceutical Revenue Growth Rate in Guillain-Barré Syndrome Business (2016-2021)
Figure 62. Akari Therapeutics Revenue Growth Rate in Guillain-Barré Syndrome Business (2016-2021)
Figure 63. China Biologic Products Holdings Revenue Growth Rate in Guillain-Barré Syndrome Business (2016-2021)
Figure 64. Biotest Revenue Growth Rate in Guillain-Barré Syndrome Business (2016-2021)
Figure 65. Kedrion Revenue Growth Rate in Guillain-Barré Syndrome Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---